Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders

RINALDI S. et al, (2020), Neurology, Neuroimmunology and Neuroinflammation

Brain hyper-excitability in DPPX ataxia.

Pattrick M. et al, (2020), J Neurol, 267, 3096 - 3099

Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology.

Binks S. and Irani SR., (2020), J Neurol Neurosurg Psychiatry, 91, 1033 - 1034

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2

Michael S. et al, (2020), Practical Neurology, 20, 377 - 384

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis

Pollak TA. et al, (2020), Molecular Psychiatry

IRAK4 deficiency presenting with anti- NMDAR encephalitis and HHV6 reactivation

IRANI S., (2020), Journal of Clinical Immunology

The B cell immunobiology that underlies CNS autoantibody-mediated diseases

Sun B. et al, (2020), Nature Reviews Neurology, 16, 481 - 492

LGI1-antibody associated epilepsy successfully treated in the outpatient setting

Uribe-San-Martín R. et al, (2020), Journal of Neuroimmunology, 345

LGI1-antibody associated epilepsy successfully treated in the outpatient setting.

Uribe-San-Martín R. et al, (2020), J Neuroimmunol, 345

Autoantibody-mediated neurological diseases

Varley JA. and Irani SR., (2020), Medicine (United Kingdom), 48, 534 - 540

Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions.

Steriade C. et al, (2020), Epilepsia, 61, 1341 - 1351

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms

Ramberger M. et al, (2020), Brain, 143, 1731 - 1745

Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing

Binks S. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 77 - 77

Hippocampal epileptogenesis in LGI1, CASPR2 and GABABR antibodies: preliminary findings

Romoli M. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 62 - 62

International multicenter examination of MOG antibody assays (vol 7, e674, 2020)

Reindl M. et al, (2020), NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 7

Real-world prevalence of autoantibodies in epilepsy

McGinty RN. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 61 - 61

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases

Kim Y. et al, (2020), Multiple Sclerosis and Related Disorders, 40, 101939 - 101939

Screening for encephalitis-causing autoantibodies in serum and CSF of first-episode psychosis patients and controls

Theorell J. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 385 - 385

International multicenter examination of MOG antibody assays

Reindl M. et al, (2020), Neurology - Neuroimmunology Neuroinflammation, 7, e674 - e674

The Immunopathogenesis of Ovarian Teratoma-associated NMDAR-Antibody Encephalitis: Mechanisms of B Cell Immunoreactions Inform a Rational Approach to Gynaecologic Operative Management.

Al-Diwani A. et al, (2020), REPRODUCTIVE SCIENCES, 27, 304A - 305A

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?